Clorox Company (The) (CLX)

Clorox Company (The)'s Q·Score is 5.7/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 546% return on equity and 11% profit margins. Key area to monitor: 21% of analysts rate it Sell or Strong Sell. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.

The consensus price target for CLX is $109.06, based on ratings from 17 Wall Street analysts. This is 25.2% above the current price of $87.11. Price targets are forward-looking estimates and not guarantees of future performance.

Clorox Company (The) (CLX) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 13.8×. The consensus analyst price target of $109.06 is 25% above the current price.

Clorox Company (The)'s next earnings report is expected on approximately July 30, 2026.

Clorox Company (The) has a net profit margin of 11.2%, which is solid for most industries. Its gross margin stands at 43.8%, reflecting a more cost-intensive business model.

Clorox Company (The) currently offers a dividend yield of 5.69%, which is considered a high-yield dividend, above the historical S&P 500 average. Dividend yields can change based on price movements and company payout decisions.

Clorox Company (The) is reporting modest revenue growth of 0.1%. Earnings are also growing at 2.7%, indicating improving profitability.

Clorox Company (The) has a debt-to-equity ratio of 48.76×, reflecting a high debt-to-equity ratio, which increases financial risk especially in rising rate environments. Its current ratio is 0.84×, suggesting it should be monitored for near-term liquidity.